Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To study if the addition of HAIC following complete removal of early stage liver cancer of
HCC will prevent or delay the recurrence of the disease. Half of the participant will receive
two cycles of the HAIC after the hepatectomy, while the other half will return to the
baseline surveillance schedule.